Home
>
National Drug Code (NDC)
>
Magnevist
Magnevist - 50419-188-02 - (Gadopentetate dimeglumine)
Drug Information of Magnevist
| Product NDC: | 50419-188 |
| Proprietary Name: | Magnevist |
| Non Proprietary Name: | Gadopentetate dimeglumine |
| Active Ingredient(s): | 469.01 mg/mL & nbsp; Gadopentetate dimeglumine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Magnevist
| Product NDC: | 50419-188 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019596 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101214 |
Package Information of Magnevist
| Package NDC: | 50419-188-02 |
| Package Description: | 20 CARTON in 1 BOX (50419-188-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Magnevist
| NDC Code | 50419-188-02 |
| Proprietary Name | Magnevist |
| Package Description | 20 CARTON in 1 BOX (50419-188-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 50419-188 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Gadopentetate dimeglumine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101214 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | GADOPENTETATE DIMEGLUMINE |
| Strength Number | 469.01 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
